⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MPLT News
MapLight Therapeutics, Inc. Common Stock
MapLight Therapeutics to Participate in Upcoming Investor Conference
globenewswire.com
MPLT
MapLight Therapeutics Celebrates Co-Founder Dr. Karl Deisseroth on Receipt of 2026 Nobel Prize in Physiology or Medicine for the Development of Optogenetics
globenewswire.com
MPLT
MapLight Therapeutics to Participate in Upcoming Investor Conference
globenewswire.com
MPLT
Form 8-K
sec.gov
MPLT
MapLight Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
globenewswire.com
MPLT
MapLight Therapeutics Announces $150 Million Private Placement Financing
globenewswire.com
MPLT
MapLight Therapeutics, Inc. (MPLT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
accessnewswire.com
MPLT
Bronstein, Gewirtz & Grossman, LLC Encourages MapLight Therapeutics, Inc. (MPLT) Shareholders to Inquire about Securities Investigation
accessnewswire.com
MPLT
Bronstein, Gewirtz & Grossman, LLC Is Investigating MapLight Therapeutics, Inc. (MPLT) And Encourages Shareholders to Connect
accessnewswire.com
MPLT
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against MapLight Therapeutics, Inc. (MPLT) And Encourages Shareholders to Reach Out
accessnewswire.com
MPLT